Gaps and opportunities in refractory status epilepticus research in children: a multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG)
- PMID: 24183923
- PMCID: PMC6387832
- DOI: 10.1016/j.seizure.2013.10.004
Gaps and opportunities in refractory status epilepticus research in children: a multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG)
Abstract
Purpose: Status epilepticus (SE) is a life-threatening condition that can be refractory to initial treatment. Randomized controlled studies to guide treatment choices, especially beyond first-line drugs, are not available. This report summarizes the evidence that guides the management of refractory convulsive SE (RCSE) in children, defines gaps in our clinical knowledge and describes the development and works of the 'pediatric Status Epilepticus Research Group' (pSERG).
Methods: A literature review was performed to evaluate current gaps in the pediatric SE and RCSE literature. In person and online meetings helped to develop and expand the pSERG network.
Results: The care of pediatric RCSE is largely based on extrapolations of limited evidence derived from adult literature and supplemented with case reports and case series in children. No comparative effectiveness trials have been performed in the pediatric population. Gaps in knowledge include risk factors for SE, biomarkers of SE and RCSE, second- and third-line treatment options, and long-term outcome.
Conclusion: The care of children with RCSE is based on limited evidence. In order to address these knowledge gaps, the multicenter pSERG was established to facilitate prospective collection, analysis, and sharing of de-identified data and biological specimens from children with RCSE. These data will allow identification of treatment strategies associated with better outcomes and delineate evidence-based interventions to improve the care of children with SE.
Keywords: Children; Epilepsy; Research network; Seizures; Status epilepticus; Treatment guidelines.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
All other authors have no disclosures or conflicts of interests related to this study.
Figures
Similar articles
-
Automated identification and quality measurement for pediatric convulsive status epilepticus.Epilepsia. 2021 Feb;62(2):337-346. doi: 10.1111/epi.16795. Epub 2020 Dec 20. Epilepsia. 2021. PMID: 33341928
-
Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus.JAMA Neurol. 2018 Apr 1;75(4):410-418. doi: 10.1001/jamaneurol.2017.4382. JAMA Neurol. 2018. PMID: 29356811 Free PMC article.
-
Admissions to paediatric intensive care units (PICU) with refractory convulsive status epilepticus (RCSE): A two-year multi-centre study.Seizure. 2015 Jul;29:153-61. doi: 10.1016/j.seizure.2015.04.002. Epub 2015 Apr 28. Seizure. 2015. PMID: 26076860
-
[Management of convulsive status epilepticus in infants and children].Rev Neurol (Paris). 2009 Apr;165(4):390-7. doi: 10.1016/j.neurol.2008.11.009. Epub 2009 Mar 4. Rev Neurol (Paris). 2009. PMID: 19264335 Review. French.
-
Status epilepticus in children.Curr Neurol Neurosci Rep. 2009 Mar;9(2):137-44. doi: 10.1007/s11910-009-0022-9. Curr Neurol Neurosci Rep. 2009. PMID: 19268037 Review.
Cited by
-
Status epilepticus and refractory status epilepticus management.Semin Pediatr Neurol. 2014 Dec;21(4):263-74. doi: 10.1016/j.spen.2014.12.006. Epub 2014 Dec 12. Semin Pediatr Neurol. 2014. PMID: 25727508 Free PMC article. Review.
-
Indications for Inpatient Magnetoencephalography in Children - An Institution's Experience.Front Hum Neurosci. 2021 Jun 4;15:667777. doi: 10.3389/fnhum.2021.667777. eCollection 2021. Front Hum Neurosci. 2021. PMID: 34149382 Free PMC article.
-
Clinical application of target temperature management in children with acute encephalopathy-A practical review.Biomed J. 2020 Jun;43(3):211-217. doi: 10.1016/j.bj.2019.12.003. Epub 2020 Jun 28. Biomed J. 2020. PMID: 32611538 Free PMC article. Review.
-
[Efficacy and safety of levetiracetam versus phenytoin as second-line drugs for the treatment of children with convulsive status epilepticus: a Meta analysis].Zhongguo Dang Dai Er Ke Za Zhi. 2021 Apr;23(4):356-362. doi: 10.7499/j.issn.1008-8830.2010066. Zhongguo Dang Dai Er Ke Za Zhi. 2021. PMID: 33840407 Free PMC article. Chinese.
-
Familial aggregation of status epilepticus in generalized and focal epilepsies.Neurology. 2020 Oct 13;95(15):e2140-e2149. doi: 10.1212/WNL.0000000000010708. Epub 2020 Sep 11. Neurology. 2020. PMID: 32917807 Free PMC article.
References
-
- Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Incidence of status epilepticus in Rochester Minnesota, 1965–1984. Neurology 1998;50: 735–41. - PubMed
-
- Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000;55:693–7. - PubMed
-
- Chin RFM, Neville BGR, Peckham C, Bedford H, Wade A, Scott RC. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet 2006;368:222–9. - PubMed
-
- Singh RK, Gaillard WD. Status epilepticus in children. Curr Neurol Neurosci Rep 2009;9:137–44. - PubMed
-
- Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993;43:483–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS075017/NS/NINDS NIH HHS/United States
- R01-NS043209/NS/NINDS NIH HHS/United States
- R01 NS065840/NS/NINDS NIH HHS/United States
- U01 NS081041/NS/NINDS NIH HHS/United States
- P30 HD040677/HD/NICHD NIH HHS/United States
- 1P30HD40677/HD/NICHD NIH HHS/United States
- R21 NS076859/NS/NINDS NIH HHS/United States
- R21 MH092615/MH/NIMH NIH HHS/United States
- MH084961/MH/NIMH NIH HHS/United States
- K08 NS048413/NS/NINDS NIH HHS/United States
- R01 NS043209/NS/NINDS NIH HHS/United States
- 2U01-NS045911/NS/NINDS NIH HHS/United States
- R01 NS062756/NS/NINDS NIH HHS/United States
- U01 DP003255/DP/NCCDPHP CDC HHS/United States
- R01-NS065840/NS/NINDS NIH HHS/United States
- R01-LM011124/LM/NLM NIH HHS/United States
- U10-NS077311/NS/NINDS NIH HHS/United States
- R01 NS067439/NS/NINDS NIH HHS/United States
- R21MH092615/MH/NIMH NIH HHS/United States
- K23 NS076550/NS/NINDS NIH HHS/United States
- U01 NS045911/NS/NINDS NIH HHS/United States
- U10 NS077311/NS/NINDS NIH HHS/United States
- R01 MH084961/MH/NIMH NIH HHS/United States
- U01 NS053998/NS/NINDS NIH HHS/United States
- R01 LM011124/LM/NLM NIH HHS/United States
- K23NS076550/NS/NINDS NIH HHS/United States
- R01-NS053998/NS/NINDS NIH HHS/United States
- R01-NS062756/NS/NINDS NIH HHS/United States
- 1R21NS076859-01/NS/NINDS NIH HHS/United States
- NS075017-01A1/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources